Karyopharm Therapeutics Inc.
KPTI
$1.61
-$0.09-5.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -81.88% | -211.84% | -156.52% | -42.46% | -37.43% |
| Total Depreciation and Amortization | -53.44% | -30.93% | -12.94% | 6.55% | -3.90% |
| Total Amortization of Deferred Charges | 1.14% | 18.33% | 65.58% | 147.29% | 396.15% |
| Total Other Non-Cash Items | 783.67% | 217.22% | 241.91% | 83.36% | 56.69% |
| Change in Net Operating Assets | -12.47% | 278.58% | 9,461.59% | 254.13% | 3,470.34% |
| Cash from Operations | 36.52% | 51.84% | 40.88% | 25.70% | 21.02% |
| Capital Expenditure | -- | -- | -- | 127.18% | 127.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.68% | -64.75% | -54.63% | -50.68% | -39.72% |
| Cash from Investing | -94.68% | -64.77% | -54.57% | -50.54% | -39.54% |
| Total Debt Issued | -67.29% | -67.29% | -67.29% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,687.84% | 4,014.60% | 555.03% | 0.00% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 89.96% | 84.01% | 85.01% | 100.00% | -307.24% |
| Cash from Financing | 7,486.49% | 91.74% | -27.85% | -97.49% | -97.49% |
| Foreign Exchange rate Adjustments | -82.76% | 70.00% | 281.82% | -105.10% | 190.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 135.24% | 573.10% | -119.99% | -222.94% | -1,511.25% |